While altered dystrophin expression leads to the developmental onset of Duchenne muscular dystrophy, it also has been associated with downregulation across various malignancies and enrichment across multiple pathways within transcriptomes of primary tumors [30]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.